Zoledronic Acid 4mg/5ml

Concentrate for solution for infusion
4mg/5ml

 

    Details

    Zoledronic Acid Fresenius Kabi focus:

    • Belongs to the class of bisphosphonates and acts primarily on bone
    • Inhibition of osteoclastic activity
    • Also possesses several anti-tumour properties that could contribute to its overall efficacy in the treatment of metastatic bone disease
    Prevention of skeletal related events:
    • Pathological fractures
    • Spinal compression
    • Radiation or surgery to the bone
    • Tumour-induced hypercalcaemia
    Treatment of adult patients with:
    • Tumour-induced hypercalcaemia (TIH)